Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Change in Cash: 2014-2024

Historic Change in Cash for Viking Therapeutics (VKTX) over the last 11 years, with Dec 2024 value amounting to -$28.7 million.

  • Viking Therapeutics' Change in Cash rose 929.28% to $66.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.1 million, marking a year-over-year increase of 280.10%. This contributed to the annual value of -$28.7 million for FY2024, which is 251.70% down from last year.
  • Per Viking Therapeutics' latest filing, its Change in Cash stood at -$28.7 million for FY2024, which was down 251.70% from $18.9 million recorded in FY2023.
  • Viking Therapeutics' 5-year Change in Cash high stood at $20.7 million for FY2020, and its period low was -$28.7 million during FY2024.
  • Over the past 3 years, Viking Therapeutics' median Change in Cash value was $10.5 million (recorded in 2022), while the average stood at $247,000.
  • As far as peak fluctuations go, Viking Therapeutics' Change in Cash surged by 483.07% in 2022, and later tumbled by 251.70% in 2024.
  • Viking Therapeutics' Change in Cash (Yearly) stood at $20.7 million in 2020, then tumbled by 113.24% to -$2.7 million in 2021, then surged by 483.07% to $10.5 million in 2022, then spiked by 79.81% to $18.9 million in 2023, then slumped by 251.70% to -$28.7 million in 2024.